All Search Results
-
Improving Care of Children with Complex Congenital Heart Disease
National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) - A Collaborative Initiative to Improve Care of Children with Complex Congenital Heart Disease
-
A U.S. Registry Of Eosinophilic Esophagitis Patients Treated With Dupixent As Standard Of Care
A U.S. Registry Of Eosinophilic Esophagitis Patients Treated With Dupixent As Standard Of Care
-
SPINEJACK IN LIEU OF FORMAL CORPECTOMY CAGES: A CASE SERIES
SpineJack in lieu of Formal Corpectomy Cages: A Case Series
-
Total Therapy for Infants With Acute Lymphoblastic Leukemia II
TINI 2: Total Therapy for Infants with Acute Lymphoblastic Leukemia II
-
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion (PICASSO) Thrombectomy Trial
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion (PICASSO) Thrombectomy Trial
-
Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
-
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
S25.184.07
-
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care A Multi-Center Prospective Registry and Retrospective Data Collection Study
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care A Multi-Center Prospective Registry and Retrospective Data Collection Study
-
EFFICACY AND COMPARISON OF TWO COMMONLY USED DOSES OF BETHANECHOL IN THE MANAGEMENT OF INFANT GASTROESOPHAGEAL REFLUX IN NEONATAL INTENSIVE CARE UNIT
EFFICACY AND COMPARISON OF TWO COMMONLY USED DOSES OF BETHANECHOL IN THE MANAGEMENT OF INFANT GASTROESOPHAGEAL REFLUX IN NEONATAL INTENSIVE CARE UNIT
-
DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients With Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy